Cargando…

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).

Between July 1979 and December 1981, 43 patients with metastatic germ-cell tumours (36 testicular non-seminomas and 7 testicular seminomas) were treated with 2-6 cycles of bleomycin, etoposide and cis-platin (BEP). Forty (93%) are alive, 37 (86%) with no evidence of disease. Of 36 men with testicula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peckham, M. J., Barrett, A., Liew, K. H., Horwich, A., Robinson, B., Dobbs, H. J., McElwain, T. J., Hendry, W. F.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1983
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011384/ https://www.ncbi.nlm.nih.gov/pubmed/6189504

Ejemplares similares

Impact of Bep or Carboplatin Chemotherapy on Testicular Function and Sperm Nucleus of Subjects with Testicular Germ Cell Tumor
por: Ghezzi, Marco, et al.
Publicado: (2016)

Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?
por: Addeo, A, et al.
Publicado: (2016)

Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial.
por: Willox, J. C., et al.
Publicado: (1986)

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2022)

MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
por: Kumar, Smriti, et al.
Publicado: (2011)

Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
por: Rimmer, Y, et al.
Publicado: (2011)

Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8).
por: Peckham, M. J., et al.
Publicado: (1985)

Interactions of doxorubicin and cis-platin in squamous carcinoma cells in culture.
por: Kohno, N., et al.
Publicado: (1988)

Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
por: Fosså, S D, et al.
Publicado: (2005)

Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.
por: Perren, T. J., et al.
Publicado: (1990)

Dendrimers Bind Antioxidant Polyphenols and cisPlatin Drug
por: Abderrezak, Amine, et al.
Publicado: (2012)

'JEB'--a carboplatin based regimen for malignant germ cell tumours in children.
por: Pinkerton, C. R., et al.
Publicado: (1990)

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)
por: Cafferty, Fay H., et al.
Publicado: (2020)

The Effects of Chemotherapeutic Agents, Bleomycin, Etoposide, and Cisplatin, on Chromatin Remodeling in Male Rat Germ Cells
por: Bagheri-Sereshki, Negar, et al.
Publicado: (2016)

Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

On the Mechanism of Action of the Antitumor Drug cis-Platin (cis-DDP) and its Second Generation Derivatives
por: Aletras, Vasilis, et al.
Publicado: (1995)

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.
por: de Wit, R., et al.
Publicado: (1995)

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.
por: Tait, D., et al.
Publicado: (1984)

High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.
por: Zulian, G. B., et al.
Publicado: (1989)

Microsatellite instability in human testicular germ cell tumours.
por: Huddart, R. A., et al.
Publicado: (1995)

Response of an ocular melanoma to subconjunctival injection of 5-thio-D-glucose or cis-platin.
por: Skov, K. A., et al.
Publicado: (1987)

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
por: Anthoney, D A, et al.
Publicado: (2004)

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
por: Huddart, Robert A., et al.
Publicado: (2015)

Adjuvant Therapy for Stage IB Germ Cell Tumors: One versus Two Cycles of BEP
por: Huddart, Robert A., et al.
Publicado: (2018)

Possible hybridization schemes for BEPS
por: Grant, A
Publicado: (1972)

Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory analysis
por: van der Schoot, Gabriela G. F., et al.
Publicado: (2023)

The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity.
por: Ohkawa, K., et al.
Publicado: (1988)

Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
por: Dady, P. J., et al.
Publicado: (1982)

Renal and haemopoietic proliferative defects as a delayed consequence of cis-platin, adriamycin and daunomycin treatments.
por: Braunschweiger, P. G., et al.
Publicado: (1982)

The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients.
por: Baak, J. P., et al.
Publicado: (1988)

Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
por: Cullen, M. H., et al.
Publicado: (1988)

Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change.
por: Summersgill, B., et al.
Publicado: (1998)

Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.
por: Kaye, S. B., et al.
Publicado: (1979)

Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours
por: Lawrence, Nicola J., et al.
Publicado: (2018)

Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.
por: Giaccone, G., et al.
Publicado: (1987)

Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats.
por: Kempf, S. R., et al.
Publicado: (1985)

Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase
por: Kimakura, Mai, et al.
Publicado: (2016)

A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
por: McElwain, T. J., et al.
Publicado: (1977)

CIS-platin increases immune activity of monocytes and cytotoxic T-cells in a murine model of epithelial ovarian cancer
por: Hopkins, Daniel, et al.
Publicado: (2021)

Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.
por: Kaye, S. B., et al.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_14ski9467lm2mnc2t0m6f9h6n3